Friends With little news on the stimulus front, and nothing new on the Covid-19 vaccine front, the market averages (other than the Nasdaq) spent most of the day in negative territory. Are we a bit overbought at the moment? Probably yes. Are stocks a bit overvalued at...
Friends The jobs number this morning was a bit disappointing, but it may end up being a part of the emphasis that helps get a stimulus deal done next week. So, despite the disappointing jobs number stocks enjoyed another good day. Once again, we are seeing much...
Friends More hope for an “interim” stimulus deal seemed to keep stocks in the green for most of the trading session, though late news that Pfizer is facing some supply chain issues for its vaccine did take some wind out of the bulls’ sails. What continues to be...
Friends It was a somewhat quiet day on the headline front and an equally quiet day on the stock trading front. The Dow and the S&P were able to squeak out a win, while the Nasdaq struggled a bit. The ADP private payroll number came in a little shy of...
Friends Stocks got quickly out of the starting gate this morning, but seemed to run out of gas as the trading session wore on. We had Mnuchin and Powell in front of the Senate Banking Committee, Biden introducing his economic team, and the Senate floating possible...
